Ipratropium (Oral Inhalation) and Moxetumomab pasudotox
Determining the interaction of Ipratropium (Oral Inhalation) and Moxetumomab pasudotox and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: ipratropium
Brand name: Atrovent HFA, Atrovent
Synonyms: Ipratropium inhalation
Generic Name: moxetumomab pasudotox
Brand name: Lumoxiti
Synonyms: Moxetumomab Pasudotox
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Ipratropium (Oral Inhalation)-Moxetumomab Pasudotox-tdfk
- Ipratropium (Oral Inhalation)-Moxetumomab pasudotox-tdfk Intravenous
- Ipratropium (Oral Inhalation)-Moxifloxacin
- Ipratropium (Oral Inhalation)-Moxifloxacin (Systemic)
- Ipratropium (Oral Inhalation)-Moxifloxacin Hydrochloride
- Ipratropium (Oral Inhalation)-Moxifloxacin Injection
- Moxetumomab pasudotox-Ipratropium and Albuterol
- Moxetumomab pasudotox-Ipratropium and Albuterol Inhalation Solution
- Moxetumomab pasudotox-Ipratropium and Albuterol Inhalation Spray
- Moxetumomab pasudotox-Ipratropium and albuterol Inhalation, oral/nebulization
- Moxetumomab pasudotox-Ipratropium Bromide
- Moxetumomab pasudotox-Ipratropium Bromide eent